Based on our knowledge about immunisation against other coronaviruses both in animals and humans, if we do get a vaccine against SARS-CoV-2, it is unlikely to be highly immunogenic or confer long-term immunity.
The WHO has issued a warning against assuming people who have been infected with SARS-CoV-2 in the past are immune against re-infection, even if antibodies are detected serologically.
About 1.13 million people had downloaded the federal government’s COVIDSafe app by 6am today, just 12 hours after its release last night, said Health Minister Greg Hunt. The government is hoping at least 40% of the population will make use of the app, designed to help reduce the spread of the coronavirus disease.
Australia’s current strategy aimed at containment and mitigation of COVID-19 is working well. Australia is in a much better place than was originally predicted according to early modelling.
On Monday April 20, Hong Kong reported no new cases of COVID-19, one of very few places around the world to have recorded such a great negative at this stage in the pandemic.
As the COVID-19 curve starts to flatten in Australia and New Zealand, people are rightly wondering how we will roll back current lockdown policies. Australia’s federal health minister Greg Hunt says Australia is looking to South Korea, Japan and Singapore to inform our exit strategy. New Zealand is relaxing some measures from next week.
It is the world-wide experience that children appear to be at low risk of experiencing symptomatic COVID-19. Because of the low numbers, there are still a number of unanswered questions with regard to the transmission and expression of the disease in this population. Many studies are currently underway, but Professor Crawford outlines the current understanding about COVID-19 in children:
Throughout the coming months, people living with osteoporosis will require ongoing treatment, and it is critical patients remain fully compliant with their medication and treatment for managing osteoporosis and bone health.
While there is little robust clinical evidence to guide the most appropriate choice and use of PPE in general practice, particularly in relation to COVID-19, knowledge about the nature of this virus can help direct efforts to prevent its spread.
There appears to be a myriad of potential treatments for our current health threat – COVID19. But just how real are these options? And which if any of these are likely to make it into our treatment regimens? A review just published online in JAMA gives us a neat summary of where we are up to in terms of treatment.
As discussed by Prof Bernie Hudson, Director of Microbiology and Infectious Diseases at Royal North Shore Hospital, Sydney in his interview with Dr Harry Nespolon on Going Viral
According to a recent analysis of COVID-19 cases among patients aged over 18 years.
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.